ロード中...
Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy
BACKGROUND: Patients with immunodeficiency diseases require lifelong treatment with immunoglobulin (Ig), yet few studies have vetted dosing strategies and effectiveness of Ig in older patient populations. Patients requiring subcutaneous (SC) Ig (SCIG) typically start with intravenous dosing before t...
保存先:
| 出版年: | Allergy Asthma Clin Immunol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4273447/ https://ncbi.nlm.nih.gov/pubmed/25535489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-014-0063-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|